Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 105
of 6Next
1:

Possible additional value of 18FDG-PET in managing pancreas intraductal papillary mucinous neoplasms: preliminary results.

Baiocchi GL, Portolani N, Bertagna F, Gheza F, Pizzocaro C, Giubbini R, Giulini SM.

J Exp Clin Cancer Res. 2008 Jun 10;27:10.

PMID: 18577196 [PubMed - indexed for MEDLINE]

2:

18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.

Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, Pedrazzoli S.

Ann Surg. 2007 Dec;246(6):932-7; discussion 937-9.

PMID: 18043094 [PubMed - indexed for MEDLINE]

3:

Positron emission tomography with 2-deoxy-2-[18f] fluoro-D-glucose in the detection of malignancy in intraductal papillary mucinous neoplasms of the pancreas.

Goh BK, Chung YF, Ng DC, Selvarajan S, Soo KC.

JOP. 2007 May 9;8(3):350-4.

PMID: 17495366 [PubMed - indexed for MEDLINE]

4:

Positron emission tomography with 2-deoxy-2-[(18)F] fluoro- d-glucose for diagnosis of intraductal papillary mucinous tumor of the pancreas with parenchymal invasion.

Yoshioka M, Sato T, Furuya T, Shibata S, Andoh H, Asanuma Y, Hatazawa J, Koyama K.

J Gastroenterol. 2003;38(12):1189-93.

PMID: 14714260 [PubMed - indexed for MEDLINE]

5:

Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.

Michaels PJ, Brachtel EF, Bounds BC, Brugge WR, Pitman MB.

Cancer. 2006 Jun 25;108(3):163-73.

PMID: 16550572 [PubMed - indexed for MEDLINE]

6:

Pancreatic juice cytology in the diagnosis of intraductal papillary mucinous neoplasm of the pancreas: significance of sampling by peroral pancreatoscopy.

Yamaguchi T, Shirai Y, Ishihara T, Sudo K, Nakagawa A, Ito H, Miyazaki M, Nomura F, Saisho H.

Cancer. 2005 Dec 15;104(12):2830-6.

PMID: 16287152 [PubMed - indexed for MEDLINE]

7:

[Diagnosis and differential diagnosis of intraductal papillary mucinous neoplasm of pancreas]

Ji Y, Tan YS, Zhu XZ, Zeng HY, Kuang TT, Jin DY.

Zhonghua Bing Li Xue Za Zhi. 2006 Feb;35(2):77-81. Chinese.

PMID: 16630480 [PubMed - indexed for MEDLINE]

8:

Value of 18-fluorodeoxyglucose positron emission tomography in the management of patients with cystic tumors of the pancreas.

Sperti C, Pasquali C, Chierichetti F, Liessi G, Ferlin G, Pedrazzoli S.

Ann Surg. 2001 Nov;234(5):675-80.

PMID: 11685032 [PubMed - indexed for MEDLINE]

9:

Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients.

Adsay NV, Conlon KC, Zee SY, Brennan MF, Klimstra DS.

Cancer. 2002 Jan 1;94(1):62-77.

PMID: 11815961 [PubMed - indexed for MEDLINE]

10:

The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer.

Bang S, Chung HW, Park SW, Chung JB, Yun M, Lee JD, Song SY.

J Clin Gastroenterol. 2006 Nov-Dec;40(10):923-9.

PMID: 17063113 [PubMed - indexed for MEDLINE]

11:

F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective study.

Sperti C, Pasquali C, Decet G, Chierichetti F, Liessi G, Pedrazzoli S.

J Gastrointest Surg. 2005 Jan;9(1):22-8; discussion 28-9.

PMID: 15623441 [PubMed - indexed for MEDLINE]

12:

Intraductal papillary-mucinous tumors of the pancreas: presentation of eight cases.

Wurzer H, Brandstätter G, Worm HC, Wolf G.

Wien Klin Wochenschr. 2001 Nov 15;113(22):880-4.

PMID: 11762126 [PubMed - indexed for MEDLINE]

13:

Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification.

Serikawa M, Sasaki T, Fujimoto Y, Kuwahara K, Chayama K.

J Clin Gastroenterol. 2006 Oct;40(9):856-62.

PMID: 17016145 [PubMed - indexed for MEDLINE]

14:

Intraductal papillary mucinous neoplasm: did it exist prior to 1980?

Tollefson MK, Libsch KD, Sarr MG, Chari ST, DiMagno EP, Urrutia R, Smyrk TC.

Pancreas. 2003 Apr;26(3):e55-8.

PMID: 12657965 [PubMed - indexed for MEDLINE]

15:

The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas.

Mansour JC, Schwartz L, Pandit-Taskar N, D'Angelica M, Fong Y, Larson SM, Brennan MF, Allen PJ.

J Gastrointest Surg. 2006 Dec;10(10):1354-60.

PMID: 17175454 [PubMed - indexed for MEDLINE]

16:

Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) --usefulness and limitations in "clinical reality".

Higashi T, Saga T, Nakamoto Y, Ishimori T, Fujimoto K, Doi R, Imamura M, Konishi J.

Ann Nucl Med. 2003 Jun;17(4):261-79. Review.

PMID: 12932109 [PubMed - indexed for MEDLINE]

17:

Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, Campbell KA, Lillemoe KD.

Ann Surg. 2004 Jun;239(6):788-97; discussion 797-9.

PMID: 15166958 [PubMed - indexed for MEDLINE]

18:

Endocrine tumor and intraductal papillary mucinous neoplasm of the pancreas: a fortuitous association?

Marrache F, Cazals-Hatem D, Kianmanesh R, Palazzo L, Couvelard A, O'Toole D, Maire F, Hammel P, Levy P, Sauvanet A, Ruszniewski P.

Pancreas. 2005 Jul;31(1):79-83.

PMID: 15968252 [PubMed - indexed for MEDLINE]

19:

Management of intraductal papillary mucinous neoplasm of the pancreas.

Sugiyama M, Suzuki Y, Abe N, Mori T, Atomi Y.

J Gastroenterol. 2008;43(3):181-5. Epub 2008 Mar 29. Review.

PMID: 18373159 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 105
of 6Next